TickerFacts.

Viridian Therapeutics, Inc. (VRDN): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Figures left out. The filed Shares Outstanding for the year ended 2013-12-31 is not shown: zero share count.

101.83M
As of 2025-12-31
113.24M
As of 2026-06-30
2014-12-31: 3.78M2015-12-31: 709.0K2016-12-31: 833.7K2017-12-31: 22.57M2018-12-31: 30.84M2019-12-31: 2.32M2020-12-31: 4.23M2021-12-31: 23.92M2022-12-31: 41.31M2023-12-31: 53.99M2024-12-31: 80.99M2025-12-31: 101.83M101.83M
2014-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31101.83M+25.7%2026-02-26, Balance as of period end
2024-12-3180.99Mn/c2026-02-26, Balance as of period end
2023-12-3153.99M+30.7%2025-03-03, Balance as of period end
2022-12-3141.31M+72.7%2024-02-27, Balance as of period end
2021-12-3123.92M+465.4%2023-03-09, Balance as of period end
2020-12-314.23M+82.1%2022-03-11, Balance as of period end
2019-12-312.32M-92.5%2021-03-26, Balance as of period end
2018-12-3130.84M+36.7%2020-03-13, Balance as of period end
2017-12-3122.57Mn/m2019-03-14, Balance as of period end
2016-12-31833.7Kn/c2018-03-15, Balance as of period end
2015-12-31709.0K-81.3%2017-03-24, Balance as of period end
2014-12-313.78Mn/a2016-03-21, Balance as of period end